lactic acid has been researched along with Blue-Eared Pig Disease in 4 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "It is unclear whether PRRSV infection can use the glucose metabolic pathway to generate immune escape in favor of viral replication." | 1.91 | Porcine reproductive and respiratory syndrome virus-mediated lactate facilitates virus replication by targeting MAVS. ( Bai, J; Gao, Y; Jiang, P; Liu, X; Mao, J; Sun, Y; Zhang, L, 2023) |
| "In vaccinated virulent heterologous PRRSV-challenged pigs, the immune correlates in the blood were as follows: 1) enhanced PRRSV-specific antibody response with enhanced avidity of both immunoglobulin (Ig)-G and IgA isotypes, associated with augmented virus-neutralizing antibody titers; 2) comparable and increased levels of virus-specific IgG₁ and IgG₂ antibody subtypes and production of high levels of both T-helper (Th)-1 and Th2 cytokines, indicative of a balanced Th1-Th2 response; 3) suppressed immunosuppressive cytokine response; 4) increased frequency of interferon-γ(+) lymphocyte subsets and expanded population of antigen-presenting cells; and most importantly 5) complete clearance of detectable replicating challenged heterologous PRRSV and close to threefold reduction in viral ribonucleic acid load detected in the blood." | 1.40 | Adjuvanted poly(lactic-co-glycolic) acid nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine elicits cross-protective immune response in pigs. ( Binjawadagi, B; Dwivedi, V; Lee, LJ; Manickam, C; Ouyang, K; Renukaradhya, GJ; Torrelles, JB; Wu, Y, 2014) |
| "The disease is caused by the PRRS virus (PRRSV), an Arterivirus which is a highly mutating RNA virus." | 1.40 | An innovative approach to induce cross-protective immunity against porcine reproductive and respiratory syndrome virus in the lungs of pigs through adjuvanted nanotechnology-based vaccination. ( Binjawadagi, B; Dwivedi, V; Manickam, C; Ouyang, K; Renukaradhya, GJ; Torrelles, JB, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, L | 1 |
| Liu, X | 1 |
| Mao, J | 1 |
| Sun, Y | 1 |
| Gao, Y | 1 |
| Bai, J | 1 |
| Jiang, P | 1 |
| Dwivedi, V | 3 |
| Manickam, C | 3 |
| Binjawadagi, B | 3 |
| Renukaradhya, GJ | 3 |
| Ouyang, K | 2 |
| Wu, Y | 1 |
| Lee, LJ | 1 |
| Torrelles, JB | 2 |
4 other studies available for lactic acid and Blue-Eared Pig Disease
| Article | Year |
|---|---|
Porcine reproductive and respiratory syndrome virus-mediated lactate facilitates virus replication by targeting MAVS.
Topics: Animals; Antiviral Agents; Female; Lactic Acid; Porcine Reproductive and Respiratory Syndrome; Porci | 2023 |
PLGA nanoparticle entrapped killed porcine reproductive and respiratory syndrome virus vaccine helps in viral clearance in pigs.
Topics: Administration, Intranasal; Animals; Antibodies, Viral; CD8-Positive T-Lymphocytes; Cytokines; Lacti | 2013 |
Adjuvanted poly(lactic-co-glycolic) acid nanoparticle-entrapped inactivated porcine reproductive and respiratory syndrome virus vaccine elicits cross-protective immune response in pigs.
Topics: Animals; Cross Protection; Lactic Acid; Nanocapsules; Polyglycolic Acid; Polylactic Acid-Polyglycoli | 2014 |
An innovative approach to induce cross-protective immunity against porcine reproductive and respiratory syndrome virus in the lungs of pigs through adjuvanted nanotechnology-based vaccination.
Topics: Animals; Cross Protection; Lactic Acid; Lung; Nanocapsules; Polyglycolic Acid; Polylactic Acid-Polyg | 2014 |